Drug recall · December 31, 2025
Merck Emend recall
Why: Presence of particulate matter: potential presence of metal particulates in the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
- Lots / codes
Lot #: Z014503, Exp 11/15/2027
- Quantity
- 3 - single dose kits
- Company
- Merck Sharp & Dohme LLC, Wilson, NC
- Distribution
- Nationwide in the USA
- Initiated
- December 12, 2025 · Voluntary: Firm initiated
- Classified
- December 23, 2025
- Reported
- December 31, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Emend
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.